

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>New frontiers in the treatment of systemic juvenile... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-971/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-971" />
    
            <meta name="description" content="Read the original article in full on F1000Research: New frontiers in the treatment of systemic juvenile idiopathic arthritis" />
    
            <meta name="og:title" content="F1000Research Article: New frontiers in the treatment of systemic juvenile idiopathic arthritis.">
            <meta name="og:description" content="Read the latest article version by Susan Canny, Elizabeth Mellins, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12227">
            <meta name="article-id" content="11327">
            <meta name="dc.title" content="New frontiers in the treatment of systemic juvenile idiopathic arthritis">
            <meta name="dc.description" content="Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment paradigm for sJIA patients. In this review, we discuss the therapies currently used in the treatment of sJIA as well as novel targets and approaches under consideration, including mesenchymal stromal cell therapy and JAK inhibitors. We also discuss targeting cytokines that have been implicated in MAS, such as interferon gamma and interleukin 18.">
            <meta name="dc.subject" content="systemic juvenile idiopathic arthritis, sJIA, macrophage activation syndrome, MAS, sJIA treatment">
            <meta name="dc.creator" content="Canny, Susan">
            <meta name="dc.creator" content="Mellins, Elizabeth">
            <meta name="dc.date" content="2017/06/22">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11327.1">
            <meta name="dc.source" content="F1000Research 2017 6:971">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="systemic juvenile idiopathic arthritis">
            <meta name="prism.keyword" content="sJIA">
            <meta name="prism.keyword" content="macrophage activation syndrome">
            <meta name="prism.keyword" content="MAS">
            <meta name="prism.keyword" content="sJIA treatment">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/06/22">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="971">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11327.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-971">
            <meta name="citation_title" content="New frontiers in the treatment of systemic juvenile idiopathic arthritis">
            <meta name="citation_abstract" content="Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment paradigm for sJIA patients. In this review, we discuss the therapies currently used in the treatment of sJIA as well as novel targets and approaches under consideration, including mesenchymal stromal cell therapy and JAK inhibitors. We also discuss targeting cytokines that have been implicated in MAS, such as interferon gamma and interleukin 18.">
            <meta name="citation_description" content="Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment paradigm for sJIA patients. In this review, we discuss the therapies currently used in the treatment of sJIA as well as novel targets and approaches under consideration, including mesenchymal stromal cell therapy and JAK inhibitors. We also discuss targeting cytokines that have been implicated in MAS, such as interferon gamma and interleukin 18.">
            <meta name="citation_keywords" content="systemic juvenile idiopathic arthritis, sJIA, macrophage activation syndrome, MAS, sJIA treatment">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Susan Canny">
            <meta name="citation_author_institution" content="Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA">
            <meta name="citation_author" content="Elizabeth Mellins">
            <meta name="citation_author_institution" content="Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA, USA">
            <meta name="citation_publication_date" content="2017/06/22">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="971">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11327.1">
            <meta name="citation_firstpage" content="971">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-971/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-971.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12227 /> <input type=hidden id=articleId name=articleId value=11327 /> <input type=hidden id=xmlUrl value="/articles/6-971/v1/xml"/> <input type=hidden id=xmlFileName value="-6-971-v1.xml"> <input type=hidden id=article_uuid value=8c303582-24cd-4f24-bc78-4a66d19083c0 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="New frontiers in the treatment of systemic juvenile idiopathic arthritis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11327.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11327.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-971"
  },
  "headline": "New frontiers in the treatment of systemic juvenile idiopathic arthritis",
  "datePublished": "2017-06-22T11:56:26",
  "dateModified": "2017-06-22T11:56:26",
  "author": [
    {
      "@type": "Person",
      "name": "Susan Canny"
    },    {
      "@type": "Person",
      "name": "Elizabeth Mellins"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment paradigm for sJIA patients. In this review, we discuss the therapies currently used in the treatment of sJIA as well as novel targets and approaches under consideration, including mesenchymal stromal cell therapy and JAK inhibitors. We also discuss targeting cytokines that have been implicated in MAS, such as interferon gamma and interleukin 18."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-971.html",
            "name": "New frontiers in the treatment of systemic juvenile idiopathic arthritis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> New frontiers in the treatment of systemic juvenile idiopathic arthritis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12227 data-id=11327 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11327.1" data-recommended="" data-doi="10.12688/f1000research.11327.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-971/v1/pdf?article_uuid=8c303582-24cd-4f24-bc78-4a66d19083c0" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11327-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11327-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11327-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Canny S and Mellins E. New frontiers in the treatment of systemic juvenile idiopathic arthritis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):971 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11327.1" target=_blank>https://doi.org/10.12688/f1000research.11327.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11327-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11327 id=track-article-signin-11327 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11327?target=/articles/6-971.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12227 /> <input name=articleId type=hidden value=11327 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>New frontiers in the treatment of systemic juvenile idiopathic arthritis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:spcanny@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Susan Canny</span></a><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:mellins@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Elizabeth Mellins</span></a><a href="https://orcid.org/0000-0003-2577-139X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2577-139X</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:spcanny@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Susan Canny</span></a><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:mellins@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Elizabeth Mellins</span></a><a href="http://orcid.org/0000-0003-2577-139X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2577-139X</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 22 Jun 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11327.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA<br/> <sup>2</sup> Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23637-23719></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23636-23720></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment paradigm for sJIA patients. In this review, we discuss the therapies currently used in the treatment of sJIA as well as novel targets and approaches under consideration, including mesenchymal stromal cell therapy and JAK inhibitors. We also discuss targeting cytokines that have been implicated in MAS, such as interferon gamma and interleukin 18. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> systemic juvenile idiopathic arthritis, sJIA, macrophage activation syndrome, MAS, sJIA treatment </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Susan Canny (<a href="mailto:spcanny@stanford.edu">spcanny@stanford.edu</a>) <br> Elizabeth Mellins (<a href="mailto:mellins@stanford.edu">mellins@stanford.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Susan Canny, Elizabeth Mellins </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Elizabeth Mellins receives sponsored research funding from Novartis. Susan Canny declares that she has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by the Systemic JIA Foundation (to EM) and the University of California at San Francisco-Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation (to EM). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Canny S and Mellins E. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Canny S and Mellins E. New frontiers in the treatment of systemic juvenile idiopathic arthritis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):971 (<a href="https://doi.org/10.12688/f1000research.11327.1" target=_blank>https://doi.org/10.12688/f1000research.11327.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 22 Jun 2017, <b>6</b>(F1000 Faculty Rev):971 (<a href="https://doi.org/10.12688/f1000research.11327.1" target=_blank>https://doi.org/10.12688/f1000research.11327.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 22 Jun 2017, <b>6</b>(F1000 Faculty Rev):971 (<a href="https://doi.org/10.12688/f1000research.11327.1" target=_blank>https://doi.org/10.12688/f1000research.11327.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d81061e187>Introduction</h2><p class="" id=d81061e190>Systemic juvenile idiopathic arthritis (sJIA) is classified as a subtype of JIA, although it is increasingly recognized as a distinct disease<sup><a href="#ref-1">1</a>–<a href="#ref-4">4</a></sup>. The ILAR classification criteria defines sJIA as arthritis in one or more joints, accompanied or preceded by systemic symptoms including quotidian fever of at least 2 weeks’ duration, an erythematous rash, lymphadenopathy, hepatomegaly, and splenomegaly and/or serositis but not associated with another diagnosis such as psoriasis, human leukocyte antigen (HLA)-B27 arthritis, inflammatory bowel disease, ankylosing spondylitis, or the presence of immunoglobulin (Ig) M rheumatoid factor<sup><a href="#ref-5">5</a></sup>. Estimates for the prevalence of JIA range from 16 to 400 cases per 100,000 children<sup><a href="#ref-6">6</a></sup>, with sJIA accounting for 4–17% of all JIA cases<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d81061e212>A proportion of children with sJIA will develop macrophage activation syndrome (MAS), with 10% developing an overt and potentially fatal clinical disease and 30–50% having occult MAS<sup><a href="#ref-7">7</a>–<a href="#ref-10">10</a></sup>. MAS is a form of secondary hemophagocytic lymphohistiocytosis (HLH) and accounts for the majority of the mortality associated with sJIA<sup><a href="#ref-1">1</a>,<a href="#ref-9">9</a></sup>. In 2016, new classification criteria for MAS in sJIA were defined, based on expert consensus and patient data, to classify patients for research studies. To be classified as having MAS, a patient must be febrile with a known or suspected diagnosis of sJIA and have a ferritin level greater than 684 ng/mL in addition to two of the following: platelet count ≤181 × 10<sup>9</sup>/L, aspartate aminotransferase (AST) &gt;48 units/L, triglycerides &gt;156 mg/dL, and/or fibrinogen ≤360 mg/dL<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>.</p><p class="" id=d81061e239>sJIA can proceed with a monophasic, polycyclic (periods of flare separated by periods of remission), or persistent course of disease<sup><a href="#ref-1">1</a>,<a href="#ref-13">13</a></sup>. When remission is defined as inactive disease off medications for at least 3 months, most patients will have either a monophasic or a persistent disease course. In one prospective cohort study, 42.2% of patients had a monophasic course, 6.7% of patients had a polycyclic course, and 51.1% of patients had persistent disease<sup><a href="#ref-13">13</a></sup>. Features associated with persistent disease include polyarticular arthritis early in disease and persistence of disease activity (specifically arthritis, elevated erythrocyte sedimentation rate [ESR], and use of corticosteroids) at 3 and 6 months<sup><a href="#ref-13">13</a></sup>. Persistent disease can be further subdivided into either predominately systemic or arthritic disease. Children with sJIA who develop persistent arthritis only (often referred to as systemic onset, polyarticular course) may represent a distinct subtype of sJIA and may benefit from distinct treatment approaches<sup><a href="#ref-14">14</a></sup>. In a recent cross-sectional analysis of North American sJIA patients, this subtype typically had more functional disability, despite a shorter time to diagnosis, and had longer disease duration, consistent with the possibility that, in some patients, sJIA evolves into this phenotype over time<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d81061e265>Recent data from a genome-wide association study of sJIA suggest that sJIA has a genetic architecture that is distinct from other forms of JIA<sup><a href="#ref-2">2</a></sup>. Whereas other subtypes of JIA have features of classic autoimmune diseases, sJIA may be better described as sharing features of both autoinflammatory and autoimmune diseases<sup><a href="#ref-1">1</a>,<a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>. Autoinflammatory diseases are mediated by cells of the innate immune system and inflammatory cytokines, such as interleukin (IL)-1 and IL-6, in contrast to the classical autoimmune diseases, which are mediated by cells of the adaptive immune system and are frequently found to be associated with specific HLA alleles<sup><a href="#ref-15">15</a>,<a href="#ref-18">18</a></sup>. Several studies suggest a role for natural killer (NK) cells, part of the innate immune system, in sJIA, particularly during MAS<sup><a href="#ref-19">19</a>–<a href="#ref-24">24</a></sup>. In the most recent study, analysis of RNA sequencing data from sJIA NK cells revealed an enrichment of inflammatory pathways with downregulation of IL-10 receptor A and granzyme K<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d81061e301>A recent study by Ombrello <i>et al</i>. described an HLA gene association (HLA-DRB1*11) with sJIA<sup><a href="#ref-16">16</a></sup>. Class II major histocompatibility complex (MHC) molecules are expressed on professional antigen-presenting cells and interact with CD4<sup>+</sup> T cells via the αβ T cell receptor, but these molecules may also play a role in the regulation of innate responses<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. As the authors note, the HLA association may reflect a contribution to sJIA pathogenesis via CD4<sup>+</sup> T cells and/or via “dysregulation of innate immunity”<sup><a href="#ref-16">16</a></sup>. Nigrovic has proposed a biphasic model of sJIA in which innate immune factors dominate the initial disease presentation, whereas adaptive immune components, such as a skewing of the CD4<sup>+</sup> T cell population to favor Th17 over regulatory T cell development, contribute in those patients in whom chronic arthritis develops<sup><a href="#ref-17">17</a></sup>. The possibility that acute systemic disease is dominated by innate factors and chronic arthritis is dominated by adaptive immune factors suggests that different treatment approaches may be warranted in different phases of disease<sup><a href="#ref-17">17</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d81061e343>Treatment</h2><p class="" id=d81061e346>Traditionally, sJIA has been treated with a combination of non-steroidal anti-inflammatory medications, such as indomethacin, and steroids. In the pre-biologic era, studies of long-term outcome reported 40–50% of sJIA patients followed for at least 10 years still had active disease<sup><a href="#ref-27">27</a></sup>. Data on the efficacy of high-dose intravenous Ig (IVIG) are conflicting<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. In practice, IVIG was often tried because of lack of steroid response or steroid toxicity, but, currently, IVIG is used less often<sup><a href="#ref-30">30</a></sup>. Methotrexate, a first-line treatment in other subtypes of JIA, has also been used for sJIA. Indeed, current recommendations from the American College of Rheumatology (ACR) include methotrexate as an option for sJIA patients with persistent arthritis<sup><a href="#ref-30">30</a></sup>. The only randomized, placebo-controlled trial of (low-dose, oral) methotrexate evaluated a group of children with persistent arthritis for &gt;1 year, many of whom also had signs of active systemic disease. The trial did not demonstrate a significant difference between methotrexate and placebo in joint scores or systemic features, suggesting that its utility in sJIA may be limited<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d81061e372>The advent of biologic medications has provided new avenues for the treatment of sJIA and options for steroid-sparing therapies<sup><a href="#ref-3">3</a></sup>. Several studies have demonstrated the efficacy of inhibitors of the inflammatory cytokines IL-1 and IL-6<sup><a href="#ref-3">3</a>,<a href="#ref-32">32</a>–<a href="#ref-37">37</a></sup>. Trials of canakinumab, a monoclonal antibody to IL-1β, and tocilizumab, a monoclonal antibody to the IL-6 receptor, showed significant clinical improvement in patients treated with these medications<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. A total of 84% of patients treated with canakinumab demonstrated clinical response compared to 10% in the placebo group<sup><a href="#ref-33">33</a></sup>. Similarly, 85% of patients treated with tocilizumab had clinical improvement compared to 24% in the placebo group<sup><a href="#ref-32">32</a></sup>. Several recent reviews nicely present further details of therapies that inhibit IL-1 and IL-6<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. Increased susceptibility to infections is observed in patients treated with these medications<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a>,<a href="#ref-40">40</a></sup>. The most common reported infections include nasopharyngitis, upper respiratory tract infections, bronchitis, and gastroenteritis, although serious bacterial infections including pneumonia and sepsis in addition to rare cases of herpesvirus infections including varicella, herpes zoster, cytomegalovirus, and Epstein-Barr virus have been reported<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a>,<a href="#ref-37">37</a>,<a href="#ref-40">40</a>–<a href="#ref-43">43</a></sup>.</p><p class="" id=d81061e438>The facts that some patients respond to biologics and others do not and that the latter group may be enriched for those with long-standing disease have given rise to a hypothesis that there is a “window of opportunity” for treatment, i.e. if patients are treated early with agents that block IL-1 or IL-6, this may modulate the course of their disease<sup><a href="#ref-17">17</a>,<a href="#ref-37">37</a>,<a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. In an uncontrolled trial of anakinra (IL-1 receptor antagonist) as first-line therapy in 20 steroid-naïve patients, &gt;80% developed inactive disease, either on or off medication, that persisted over a mean follow-up of &gt;2 years<sup><a href="#ref-44">44</a></sup>. However, the fraction of these patients with monocyclic disease that would have remitted without biologic therapy is not known. Currently, it remains uncertain whether there is truly a window of opportunity or a subset of patients in whom such treatments are effective.</p><p class="" id=d81061e458>Although many patients respond to IL-1 and IL-6 inhibition, a subset of patients continues to have refractory sJIA. Nearly one-third of patients develop persistent polyarthritis after resolution of the systemic symptoms<sup><a href="#ref-14">14</a></sup>. For these patients, medications including abatacept, a CTLA-4 fusion protein that blocks T cell co-stimulation via CD80/CD86, have demonstrated some efficacy<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Several sJIA patients with refractory disease, including some with persistent arthritis, were treated with abatacept in combination with anakinra with clinical improvement and ability to reduce doses of anakinra and steroids<sup><a href="#ref-47">47</a></sup>. The fact that abatacept, which blocks T cell activation, is effective in some refractory sJIA cases suggests new therapeutic targets for these patients and a possible role for T cells in refractory disease.</p><p class="" id=d81061e477>There is no current consensus on the optimal way to treat recurrent MAS in sJIA. A range of approaches is used from a combination of steroids, IL-1 inhibitors, and cyclosporine to etoposide with steroids (based on HLH treatment protocols) to stem cell transplantation. Treatment protocols for HLH developed by the Histiocyte Society include etoposide and steroids with or without cyclosporine and intrathecal methotrexate and steroids followed by bone marrow transplantation for patients with familial HLH or refractory secondary HLH<sup><a href="#ref-48">48</a>–<a href="#ref-51">51</a></sup>. In patients with sJIA, the emphasis typically has been on controlling the underlying disease<sup><a href="#ref-48">48</a></sup>. However, it is worth noting that MAS, triggered by infections, occurs even when patients’ underlying sJIA is controlled<sup><a href="#ref-42">42</a></sup>. As discussed below, new approaches may hold promise for the treatment of refractory MAS, given their efficacy in animal models of HLH.</p><p class="" id=d81061e495>Hematopoietic stem cell transplantation (HSCT) has been used to treat severe refractory sJIA<sup><a href="#ref-52">52</a>–<a href="#ref-54">54</a></sup>. Following several deaths in transplant patients due to virally induced MAS, investigators aimed to achieve improved control of disease prior to transplantation; the conditioning protocol was amended to mitigate T cell depletion, and patients were placed on antiviral prophylaxis after transplantation<sup><a href="#ref-52">52</a></sup>. Data suggest that HSCT allows for a resetting of the immune regulatory network with a recovery of regulatory T cells<sup><a href="#ref-55">55</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d81061e516>On the horizon</h2><p class="" id=d81061e519>Given the risks associated with HSCT and the advent of biologic medications, the use of allogeneic stem cell transplants in sJIA has declined<sup><a href="#ref-56">56</a></sup>. Investigators are now exploring the possibility of multipotent mesenchymal stromal cell (MSC) therapy as an alternative for the treatment of autoimmune diseases refractory to other treatments. Studies have shown that MSCs have immunomodulatory properties and are well tolerated<sup><a href="#ref-56">56</a>–<a href="#ref-59">59</a></sup>. In 10 patients with JIA treated with MSCs, markers of inflammation (ESR and C-reactive protein [CRP]) were significantly decreased and regulatory T cells were significantly increased<sup><a href="#ref-60">60</a></sup>. Additional larger studies are warranted.</p><p class="" id=d81061e537>Evidence suggests that the cytokine interferon gamma (IFNγ) plays an important role specifically in MAS<sup><a href="#ref-38">38</a>,<a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. Levels of IFNγ and IFNγ-induced genes are not elevated in patients with sJIA without signs of MAS<sup><a href="#ref-63">63</a>–<a href="#ref-65">65</a></sup>. In contrast, in patients with sJIA complicated by MAS, IFNγ levels and IFNγ-induced gene expression increase<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. A phase II/III trial is currently underway to assess the efficacy of an anti-IFNγ monoclonal antibody in primary HLH. Based on the evidence for a role for IFNγ in MAS, targeting IFNγ in secondary HLH may also prove fruitful.</p><p class="" id=d81061e564>The cytokine IL-18 is another potential target in sJIA, as studies have shown that patients with sJIA have high levels of IL-18 and substantially increased levels may be associated with risk of MAS<sup><a href="#ref-66">66</a>–<a href="#ref-70">70</a></sup>. The IL-18 binding protein (IL-18BP) regulates IL-18 action; it binds IL-18 with high affinity and inhibits its activity<sup><a href="#ref-71">71</a></sup>. Administration of synthetic IL-18BP in a mouse model of HLH (perforin-1-knockout mice infected with murine cytomegalovirus) diminished liver and spleen damage and reduced levels of the inflammatory cytokines IFNγ and TNFα, although it did not alter survival<sup><a href="#ref-72">72</a></sup>. Notably, elevated levels of IL-18 persist for at least a few months in clinical remission of sJIA<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>, suggesting that further research is needed to clarify the role of IL-18 in disease pathogenesis and control of disease. A recent case report has demonstrated the potential utility of recombinant IL-18BP in a patient with an MAS-like syndrome due to mutation of NLRC4, a protein that triggers activation of the inflammasome<sup><a href="#ref-73">73</a></sup>. Whether IL-18BP will be effective clinically in sJIA or MAS remains to be seen and, if so, whether the timing of administration determines clinical response.</p><p class="" id=d81061e593>Another possible cytokine target is IL-17. As noted above, Th17 cells have been proposed to play a pathogenic role in the chronic arthritic phase of sJIA<sup><a href="#ref-17">17</a></sup>. IL-17-producing T cells (CD4<sup>+</sup> and CD4<sup>–</sup>) have been found at higher proportions in the peripheral blood of sJIA patients compared to healthy, age-matched controls<sup><a href="#ref-74">74</a></sup>. Biologic agents modulating the action of IL-17 are in various stages of investigation in the treatment of psoriasis, psoriatic arthritis, and rheumatoid arthritis<sup><a href="#ref-75">75</a></sup> and may be worth considering in the treatment of sJIA patients with chronic arthritis.<b></b></p><p class="" id=d81061e617>Cytokines signal through their cell surface receptors to induce changes in gene transcription. Signaling molecules include the enzymes in the Janus kinase (JAK) family. New small molecule inhibitors of JAKs are under development. Tofacitinib, an inhibitor of JAK1 and JAK3, has been found to be effective in adults with rheumatoid arthritis<sup><a href="#ref-76">76</a></sup>. Varicella zoster virus reactivation and cytomegalovirus infection have been reported in patients on tofacitinib, although no cases of Epstein-Barr virus, a common MAS trigger, have been reported<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>. Given the association of viral triggers with MAS, JAK inhibitors, at least tofacitinib, may be less attractive as therapeutic options in patients at risk of developing MAS<sup><a href="#ref-20">20</a>,<a href="#ref-42">42</a>,<a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. In contrast, ruxolitinib, an inhibitor of JAK1 and JAK2, has been tested in mouse models of HLH and found to promote survival and reduce levels of pro-inflammatory cytokines IL-6 and TNFα<sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>, suggesting that JAK1/2 may be a therapeutic target in patients with HLH. Whether these small molecule JAK inhibitors will be effective in sJIA or MAS in children requires further study.</p><p class="" id=d81061e651>Given the small numbers of patients with sJIA, collaborative research and research networks, such as the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Paediatric Rheumatology International Trials Organisation (PRINTO), and the Pediatric Rheumatology Collaborative Study Group (PRCSG), will likely play an important role in developing the next generation of sJIA treatments. CARRA has developed consensus treatment plans for sJIA to be used in comparative efficacy trials of different treatments<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>. The ACR has recently developed comprehensive guidelines for the treatment of sJIA based on disease activity and disease phenotype<sup><a href="#ref-30">30</a></sup>. Understanding the pathogenesis of sJIA and its complications, including MAS and refractory arthritis, will be important in defining new therapeutic targets and ensuring that clinical treatments optimize therapeutic outcomes while minimizing treatment toxicities.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d81061e1 class=n-a></a><h2 class=main-title id=d81305>Competing interests</h2><p class=metadata-entry><a name=d81061e104 class=n-a></a><p id=d81061e106> Elizabeth Mellins receives sponsored research funding from Novartis. Susan Canny declares that she has no competing interests.</p></p></div><div class=back-section><a name=d81061e1 class=n-a></a><h2 class=main-title id=d81307>Grant information</h2><p>This work was supported by the Systemic JIA Foundation (to EM) and the University of California at San Francisco-Stanford Arthritis Center of Excellence, funded by the Great Western Region of the Arthritis Foundation (to EM).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d81061e669 class=n-a></a><h2 class=main-title id=d81061e671>Acknowledgements</h2><p class="" id=d81061e674>The authors thank Drs. Alexei Grom and Randy Cron for critical reading of the manuscript.</p></div><div class=back-section><a name=d81061e678 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d81581>References</h2><div class="section ref-list"><a name=d81061e678 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718303443"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e685 class=n-a></a>Mellins ED, Macaubas C, Grom AA: Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. <i>Nat Rev Rheumatol.</i> 2011; <b>7</b>(7): 416–26. <a target=xrefwindow id=d81061e693 href="http://www.ncbi.nlm.nih.gov/pubmed/21647204">PubMed Abstract </a> | <a target=xrefwindow id=d81061e696 href="http://dx.doi.org/10.1038/nrrheum.2011.68">Publisher Full Text </a> | <a target=xrefwindow id=d81061e699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4180659">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718303443">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d81061e712 class=n-a></a>Ombrello MJ, Arthur VL, Remmers EF, <i> et al.</i>: Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(5): 906–13. <a target=xrefwindow id=d81061e723 href="http://www.ncbi.nlm.nih.gov/pubmed/27927641">PubMed Abstract </a> | <a target=xrefwindow id=d81061e726 href="http://dx.doi.org/10.1136/annrheumdis-2016-210324">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d81061e735 class=n-a></a>Sandborg C, Mellins ED: A new era in the treatment of systemic juvenile idiopathic arthritis. <i>N Engl J Med.</i> 2012; <b>367</b>(25): 2439–40. <a target=xrefwindow id=d81061e743 href="http://www.ncbi.nlm.nih.gov/pubmed/23252530">PubMed Abstract </a> | <a target=xrefwindow id=d81061e746 href="http://dx.doi.org/10.1056/NEJMe1212640">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d81061e755 class=n-a></a>Woo P: Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. <i>Nat Clin Pract Rheumatol.</i> 2006; <b>2</b>(1): 28–34. <a target=xrefwindow id=d81061e763 href="http://www.ncbi.nlm.nih.gov/pubmed/16932649">PubMed Abstract </a> | <a target=xrefwindow id=d81061e766 href="http://dx.doi.org/10.1038/ncprheum0084">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d81061e775 class=n-a></a>Petty RE, Southwood TR, Manners P, <i> et al.</i>: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. <i>J Rheumatol.</i> 2004; <b>31</b>(2): 390–2. <a target=xrefwindow id=d81061e786 href="http://www.ncbi.nlm.nih.gov/pubmed/14760812">PubMed Abstract </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d81061e796 class=n-a></a>Ravelli A, Martini A: Juvenile idiopathic arthritis. <i>Lancet.</i> 2007; <b>369</b>(9563): 767–78. <a target=xrefwindow id=d81061e804 href="http://www.ncbi.nlm.nih.gov/pubmed/17336654">PubMed Abstract </a> | <a target=xrefwindow id=d81061e807 href="http://dx.doi.org/10.1016/S0140-6736(07)60363-8">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d81061e816 class=n-a></a>Grom AA, Mellins ED: Macrophage activation syndrome: advances towards understanding pathogenesis. <i>Curr Opin Rheumatol.</i> 2010; <b>22</b>(5): 561–6. <a target=xrefwindow id=d81061e824 href="http://www.ncbi.nlm.nih.gov/pubmed/20517154">PubMed Abstract </a> | <a target=xrefwindow id=d81061e827 href="http://dx.doi.org/10.1097/01.bor.0000381996.69261.71">Publisher Full Text </a> | <a target=xrefwindow id=d81061e830 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4443835">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d81061e839 class=n-a></a>Behrens EM, Beukelman T, Paessler M, <i> et al.</i>: Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. <i>J Rheumatol.</i> 2007; <b>34</b>(5): 1133–8. <a target=xrefwindow id=d81061e850 href="http://www.ncbi.nlm.nih.gov/pubmed/17343315">PubMed Abstract </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d81061e859 class=n-a></a>Minoia F, Davì S, Horne A, <i> et al.</i>: Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(11): 3160–9. <a target=xrefwindow id=d81061e870 href="http://www.ncbi.nlm.nih.gov/pubmed/25077692">PubMed Abstract </a> | <a target=xrefwindow id=d81061e873 href="http://dx.doi.org/10.1002/art.38802">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d81061e882 class=n-a></a>Sawhney S, Woo P, Murray KJ: Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. <i>Arch Dis Child.</i> 2001; <b>85</b>(5): 421–6. <a target=xrefwindow id=d81061e890 href="http://www.ncbi.nlm.nih.gov/pubmed/11668110">PubMed Abstract </a> | <a target=xrefwindow id=d81061e893 href="http://dx.doi.org/10.1136/adc.85.5.421">Publisher Full Text </a> | <a target=xrefwindow id=d81061e896 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1718981">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725755439"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e905 class=n-a></a>Ravelli A, Minoia F, Davi S, <i> et al.</i>: 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(3): 566–76. <a target=xrefwindow id=d81061e916 href="http://www.ncbi.nlm.nih.gov/pubmed/26314788">PubMed Abstract </a> | <a target=xrefwindow id=d81061e919 href="http://dx.doi.org/10.1002/art.39332">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725755439">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726157342"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e933 class=n-a></a>Ravelli A, Minoia F, Davi S, <i> et al.</i>: 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(3): 481–9. <a target=xrefwindow id=d81061e944 href="http://www.ncbi.nlm.nih.gov/pubmed/26865703">PubMed Abstract </a> | <a target=xrefwindow id=d81061e947 href="http://dx.doi.org/10.1136/annrheumdis-2015-208982">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726157342">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718303442"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e960 class=n-a></a>Singh-Grewal D, Schneider R, Bayer N, <i> et al.</i>: Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. <i>Arthritis Rheum.</i> 2006; <b>54</b>(5): 1595–601. <a target=xrefwindow id=d81061e971 href="http://www.ncbi.nlm.nih.gov/pubmed/16645998">PubMed Abstract </a> | <a target=xrefwindow id=d81061e974 href="http://dx.doi.org/10.1002/art.21774">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718303442">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d81061e987 class=n-a></a>Janow G, Schanberg LE, Setoguchi S, <i> et al.</i>: The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. <i>J Rheumatol.</i> 2016; <b>43</b>(9): 1755–62. <a target=xrefwindow id=d81061e998 href="http://www.ncbi.nlm.nih.gov/pubmed/27307527">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1001 href="http://dx.doi.org/10.3899/jrheum.150997">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d81061e1010 class=n-a></a>McGonagle D, Aziz A, Dickie LJ, <i> et al.</i>: An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum. <i>Pediatr Res.</i> 2009; <b>65</b>(5 Pt 2): 38R–45R. <a target=xrefwindow id=d81061e1021 href="http://www.ncbi.nlm.nih.gov/pubmed/19190531">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1024 href="http://dx.doi.org/10.1203/PDR.0b013e31819dbd0a">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d81061e1033 class=n-a></a>Ombrello MJ, Remmers EF, Tachmazidou I, <i> et al.</i>: <i>HLA-DRB1*11</i> and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(52): 15970–5. <a target=xrefwindow id=d81061e1047 href="http://www.ncbi.nlm.nih.gov/pubmed/26598658">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1051 href="http://dx.doi.org/10.1073/pnas.1520779112">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1054 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4702958">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d81061e1063 class=n-a></a>Nigrovic PA: Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(6): 1405–13. <a target=xrefwindow id=d81061e1071 href="http://www.ncbi.nlm.nih.gov/pubmed/24623686">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1074 href="http://dx.doi.org/10.1002/art.38615">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d81061e1084 class=n-a></a>Hashkes PJ, Toker O: Autoinflammatory syndromes. <i>Pediatr Clin North Am.</i> 2012; <b>59</b>(2): 447–70. <a target=xrefwindow id=d81061e1092 href="http://www.ncbi.nlm.nih.gov/pubmed/22560579">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1095 href="http://dx.doi.org/10.1016/j.pcl.2012.03.005">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d81061e1104 class=n-a></a>Villanueva J, Lee S, Giannini EH, <i> et al.</i>: Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. <i>Arthritis Res Ther.</i> 2005; <b>7</b>(1): R30–7. <a target=xrefwindow id=d81061e1115 href="http://www.ncbi.nlm.nih.gov/pubmed/15642140">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1118 href="http://dx.doi.org/10.1186/ar1453">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1122 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1064882">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d81061e1131 class=n-a></a>Grom AA, Villanueva J, Lee S, <i> et al.</i>: Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. <i>J Pediatr.</i> 2003; <b>142</b>(3): 292–6. <a target=xrefwindow id=d81061e1142 href="http://www.ncbi.nlm.nih.gov/pubmed/12640378">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1145 href="http://dx.doi.org/10.1067/mpd.2003.110">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d81061e1154 class=n-a></a>Avau A, Put K, Wouters CH, <i> et al.</i>: Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. <i>Cytokine Growth Factor Rev.</i> 2015; <b>26</b>(1): 35–45. <a target=xrefwindow id=d81061e1165 href="http://www.ncbi.nlm.nih.gov/pubmed/24948570">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1168 href="http://dx.doi.org/10.1016/j.cytogfr.2014.05.005">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d81061e1177 class=n-a></a>Zhou J, Tang X, Ding Y, <i> et al.</i>: Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. <i>Pediatr Allergy Immunol.</i> 2013; <b>24</b>(7): 691–6. <a target=xrefwindow id=d81061e1188 href="http://www.ncbi.nlm.nih.gov/pubmed/24112428">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1191 href="http://dx.doi.org/10.1111/pai.12130">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726815653"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1200 class=n-a></a>Put K, Vandenhaute J, Avau A, <i> et al.</i>: Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(1): 213–24. <a target=xrefwindow id=d81061e1211 href="http://www.ncbi.nlm.nih.gov/pubmed/27696741">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1214 href="http://dx.doi.org/10.1002/art.39933">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726815653">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d81061e1228 class=n-a></a>de Jager W, Vastert SJ, Beekman JM, <i> et al.</i>: Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. <i>Arthritis Rheum.</i> 2009; <b>60</b>(9): 2782–93. <a target=xrefwindow id=d81061e1239 href="http://www.ncbi.nlm.nih.gov/pubmed/19714583">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1242 href="http://dx.doi.org/10.1002/art.24750">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d81061e1251 class=n-a></a>Jones EY, Fugger L, Strominger JL, <i> et al.</i>: MHC class II proteins and disease: a structural perspective. <i>Nat Rev Immunol.</i> 2006; <b>6</b>(4): 271–82. <a target=xrefwindow id=d81061e1262 href="http://www.ncbi.nlm.nih.gov/pubmed/16557259">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1265 href="http://dx.doi.org/10.1038/nri1805">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d81061e1274 class=n-a></a>Liu X, Zhan Z, Li D, <i> et al.</i>: Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. <i>Nat Immunol.</i> 2011; <b>12</b>(5): 416–24. <a target=xrefwindow id=d81061e1285 href="http://www.ncbi.nlm.nih.gov/pubmed/21441935">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1288 href="http://dx.doi.org/10.1038/ni.2015">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d81061e1297 class=n-a></a>Wallace CA, Levinson JE: Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. <i>Rheum Dis Clin North Am.</i> 1991; <b>17</b>(4): 891–905. <a target=xrefwindow id=d81061e1305 href="http://www.ncbi.nlm.nih.gov/pubmed/1767079">PubMed Abstract </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d81061e1314 class=n-a></a>Silverman ED, Laxer RM, Greenwald M, <i> et al.</i>: Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis. <i>Arthritis Rheum.</i> 1990; <b>33</b>(7): 1015–22. <a target=xrefwindow id=d81061e1325 href="http://www.ncbi.nlm.nih.gov/pubmed/1695098">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1328 href="http://dx.doi.org/10.1002/art.1780330714">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d81061e1337 class=n-a></a>Silverman ED, Cawkwell GD, Lovell DJ, <i> et al.</i>: Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. <i>J Rheumatol.</i> 1994; <b>21</b>(12): 2353–8. <a target=xrefwindow id=d81061e1348 href="http://www.ncbi.nlm.nih.gov/pubmed/7699642">PubMed Abstract </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d81061e1358 class=n-a></a>Ringold S, Weiss PF, Beukelman T, <i> et al.</i>: 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. <i>Arthritis Rheum.</i> 2013; <b>65</b>(10): 2499–512. <a target=xrefwindow id=d81061e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/24092554">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1372 href="http://dx.doi.org/10.1002/art.38092">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1376 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5408575">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718303444"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1385 class=n-a></a>Woo P, Southwood TR, Prieur AM, <i> et al.</i>: Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. <i>Arthritis Rheum.</i> 2000; <b>43</b>(8): 1849–57. <a target=xrefwindow id=d81061e1396 href="http://www.ncbi.nlm.nih.gov/pubmed/10943876">PubMed Abstract </a> | <a target="xrefwindow" id="d81061e1399" href="http://dx.doi.org/10.1002/1529-0131(200008)43:8<1849::AID-ANR22&gt;3.0.CO;2-F">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718303444">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717968745"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1412 class=n-a></a>De Benedetti F, Brunner HI, Ruperto N, <i> et al.</i>: Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. <i>N Engl J Med.</i> 2012; <b>367</b>(25): 2385–95. <a target=xrefwindow id=d81061e1423 href="http://www.ncbi.nlm.nih.gov/pubmed/23252525">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1426 href="http://dx.doi.org/10.1056/NEJMoa1112802">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717968745">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717968744"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1439 class=n-a></a>Ruperto N, Brunner HI, Quartier P, <i> et al.</i>: Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. <i>N Engl J Med.</i> 2012; <b>367</b>(25): 2396–406. <a target=xrefwindow id=d81061e1450 href="http://www.ncbi.nlm.nih.gov/pubmed/23252526">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1453 href="http://dx.doi.org/10.1056/NEJMoa1205099">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717968744">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1031253"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1466 class=n-a></a>Pascual V, Allantaz F, Arce E, <i> et al.</i>: Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. <i>J Exp Med.</i> 2005; <b>201</b>(9): 1479–86. <a target=xrefwindow id=d81061e1477 href="http://www.ncbi.nlm.nih.gov/pubmed/15851489">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1480 href="http://dx.doi.org/10.1084/jem.20050473">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1484 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2213182">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1031253">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718303447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1497 class=n-a></a>Verbsky JW, White AJ: Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. <i>J Rheumatol.</i> 2004; <b>31</b>(10): 2071–5. <a target=xrefwindow id=d81061e1505 href="http://www.ncbi.nlm.nih.gov/pubmed/15468378">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1508 href="http://dx.doi.org/10.3410/f.718303447.793491942">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718303447">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d81061e1522 class=n-a></a>Yokota S, Miyamae T, Imagawa T, <i> et al.</i>: Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. <i>Arthritis Rheum.</i> 2005; <b>52</b>(3): 818–25. <a target=xrefwindow id=d81061e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/15751095">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1536 href="http://dx.doi.org/10.1002/art.20944">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718303449"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1545 class=n-a></a>Nigrovic PA, Mannion M, Prince FH, <i> et al.</i>: Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. <i>Arthritis Rheum.</i> 2011; <b>63</b>(2): 545–55. <a target=xrefwindow id=d81061e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/21280009">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1559 href="http://dx.doi.org/10.1002/art.30128">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718303449">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726232447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1572 class=n-a></a>Grom AA, Horne A, de Benedetti F: Macrophage activation syndrome in the era of biologic therapy. <i>Nat Rev Rheumatol.</i> 2016; <b>12</b>(5): 259–68. <a target=xrefwindow id=d81061e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/27009539">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1583 href="http://dx.doi.org/10.1038/nrrheum.2015.179">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726232447">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718421267"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1596 class=n-a></a>Beukelman T: Treatment advances in systemic juvenile idiopathic arthritis. <i>F1000Prime Rep.</i> 2014; <b>6</b>: 21. <a target=xrefwindow id=d81061e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/24765526">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1607 href="http://dx.doi.org/10.12703/P6-21">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1610 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3974570">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718421267">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d81061e1623 class=n-a></a>Yokota S, Imagawa T, Mori M, <i> et al.</i>: Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan. <i>J Rheumatol.</i> 2014; <b>41</b>(4): 759–67. <a target=xrefwindow id=d81061e1634 href="http://www.ncbi.nlm.nih.gov/pubmed/24634205">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1637 href="http://dx.doi.org/10.3899/jrheum.130690">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725998853"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1646 class=n-a></a>Yokota S, Itoh Y, Morio T, <i> et al.</i>: Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(9): 1654–60. <a target=xrefwindow id=d81061e1657 href="http://www.ncbi.nlm.nih.gov/pubmed/26644233">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1660 href="http://dx.doi.org/10.1136/annrheumdis-2015-207818">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1664 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5013079">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725998853">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725755448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1678 class=n-a></a>Grom AA, Ilowite NT, Pascual V, <i> et al.</i>: Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(1): 218–28. <a target=xrefwindow id=d81061e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/26314396">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1692 href="http://dx.doi.org/10.1002/art.39407">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725755448">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d81061e1705 class=n-a></a>Ilowite NT, Prather K, Lokhnygina Y, <i> et al.</i>: Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(9): 2570–9. <a target=xrefwindow id=d81061e1716 href="http://www.ncbi.nlm.nih.gov/pubmed/24839206">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1719 href="http://dx.doi.org/10.1002/art.38699">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4314719">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d81061e1732 class=n-a></a>Vastert SJ, de Jager W, Noordman BJ, <i> et al.</i>: Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(4): 1034–43. <a target=xrefwindow id=d81061e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/24757154">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1746 href="http://dx.doi.org/10.1002/art.38296">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718314314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1755 class=n-a></a>Otten MH, Anink J, Prince FH, <i> et al.</i>: Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(7): 1379–86. <a target=xrefwindow id=d81061e1766 href="http://www.ncbi.nlm.nih.gov/pubmed/24641940">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1769 href="http://dx.doi.org/10.1136/annrheumdis-2013-204641">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718314314">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d81061e1782 class=n-a></a>Ruperto N, Lovell DJ, Quartier P, <i> et al.</i>: Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. <i>Arthritis Rheum.</i> 2010; <b>62</b>(6): 1792–802. <a target=xrefwindow id=d81061e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/20191582">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1796 href="http://dx.doi.org/10.1002/art.27431">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d81061e1805 class=n-a></a>Record JL, Beukelman T, Cron RQ: Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. <i>J Rheumatol.</i> 2011; <b>38</b>(1): 180–1. <a target=xrefwindow id=d81061e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/21196588">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1816 href="http://dx.doi.org/10.3899/jrheum.100726">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d81061e1826 class=n-a></a>Jordan MB, Allen CE, Weitzman S, <i> et al.</i>: How I treat hemophagocytic lymphohistiocytosis. <i>Blood.</i> 2011; <b>118</b>(15): 4041–52. <a target=xrefwindow id=d81061e1837 href="http://www.ncbi.nlm.nih.gov/pubmed/21828139">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1840 href="http://dx.doi.org/10.1182/blood-2011-03-278127">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1844 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3204727">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d81061e1853 class=n-a></a>Henter JI, Aricò M, Egeler RM, <i> et al.</i>: HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. <i>Med Pediatr Oncol.</i> 1997; <b>28</b>(5): 342–7. <a target=xrefwindow id=d81061e1864 href="http://www.ncbi.nlm.nih.gov/pubmed/9121398">PubMed Abstract </a> | <a target="xrefwindow" id="d81061e1867" href="http://dx.doi.org/10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3&gt;3.0.CO;2-H">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d81061e1876 class=n-a></a>Henter J, Horne A, Aricó M, <i> et al.</i>: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. <i>Pediatr Blood Cancer.</i> 2007; <b>48</b>(2): 124–31. <a target=xrefwindow id=d81061e1887 href="http://www.ncbi.nlm.nih.gov/pubmed/16937360">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1890 href="http://dx.doi.org/10.1002/pbc.21039">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d81061e1899 class=n-a></a>Henter JI, Samuelsson-Horne A, Aricò M, <i> et al.</i>: Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. <i>Blood.</i> 2002; <b>100</b>(7): 2367–73. <a target=xrefwindow id=d81061e1910 href="http://www.ncbi.nlm.nih.gov/pubmed/12239144">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1913 href="http://dx.doi.org/10.1182/blood-2002-01-0172">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d81061e1922 class=n-a></a>Brinkman DM, de Kleer IM, ten Cate R, <i> et al.</i>: Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. <i>Arthritis Rheum.</i> 2007; <b>56</b>(7): 2410–21. <a target=xrefwindow id=d81061e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/17599770">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1936 href="http://dx.doi.org/10.1002/art.22656">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d81061e1945 class=n-a></a>Wulffraat NM, Brinkman D, Ferster A, <i> et al.</i>: Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. <i>Bone Marrow Transplant.</i> 2003; <b>32</b>(Suppl 1): S61–4. <a target=xrefwindow id=d81061e1956 href="http://www.ncbi.nlm.nih.gov/pubmed/12931245">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1959 href="http://dx.doi.org/10.1038/sj.bmt.1703946">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d81061e1969 class=n-a></a>De Kleer IM, Brinkman DM, Ferster A, <i> et al.</i>: Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. <i>Ann Rheum Dis.</i> 2004; <b>63</b>(10): 1318–26. <a target=xrefwindow id=d81061e1980 href="http://www.ncbi.nlm.nih.gov/pubmed/15361393">PubMed Abstract </a> | <a target=xrefwindow id=d81061e1983 href="http://dx.doi.org/10.1136/ard.2003.017798">Publisher Full Text </a> | <a target=xrefwindow id=d81061e1987 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1754760">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1028977"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e1996 class=n-a></a>de Kleer I, Vastert B, Klein M, <i> et al.</i>: Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4<sup>+</sup>CD25<sup>+</sup> immune regulatory network. <i>Blood.</i> 2006; <b>107</b>(4): 1696–702. <a target=xrefwindow id=d81061e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/16263787">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2017 href="http://dx.doi.org/10.1182/blood-2005-07-2800">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1028977">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727338480"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2030 class=n-a></a>Swart JF, Delemarre EM, van Wijk F, <i> et al.</i>: Haematopoietic stem cell transplantation for autoimmune diseases. <i>Nat Rev Rheumatol.</i> 2017; <b>13</b>(4): 244–56. <a target=xrefwindow id=d81061e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/28228650">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2044 href="http://dx.doi.org/10.1038/nrrheum.2017.7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727338480">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d81061e2057 class=n-a></a>Swart JF, Wulffraat NM: Mesenchymal stromal cells for treatment of arthritis. <i>Best Pract Res Clin Rheumatol.</i> 2014; <b>28</b>(4): 589–603. <a target=xrefwindow id=d81061e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/25481552">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2068 href="http://dx.doi.org/10.1016/j.berh.2014.10.023">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725906901"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2077 class=n-a></a>Cras A, Farge D, Carmoi T, <i> et al.</i>: Update on mesenchymal stem cell-based therapy in lupus and scleroderma. <i>Arthritis Res Ther.</i> 2015; <b>17</b>: 301. <a target=xrefwindow id=d81061e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/26525582">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2091 href="http://dx.doi.org/10.1186/s13075-015-0819-7">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2095 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4631077">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725906901">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d81061e2108 class=n-a></a>Wang L, Wang L, Cong X, <i> et al.</i>: Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. <i>Stem Cells Dev.</i> 2013; <b>22</b>(24): 3192–202. <a target=xrefwindow id=d81061e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/23941289">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2122 href="http://dx.doi.org/10.1089/scd.2013.0023">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726077742"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2132 class=n-a></a>Wang L, Zhang Y, Li H, <i> et al.</i>: Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy. <i>Stem Cells Int.</i> 2016; <b>2016</b>: 9165267. <a target=xrefwindow id=d81061e2143 href="http://www.ncbi.nlm.nih.gov/pubmed/26770214">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2146 href="http://dx.doi.org/10.1155/2016/9165267">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2150 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4684881">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726077742">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726422069"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2163 class=n-a></a>Bracaglia C, de Graaf K, Pires Marafon D, <i> et al.</i>: Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(1): 166–72. <a target=xrefwindow id=d81061e2174 href="http://www.ncbi.nlm.nih.gov/pubmed/27296321">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2177 href="http://dx.doi.org/10.1136/annrheumdis-2015-209020">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726422069">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725388875"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2190 class=n-a></a>Put K, Avau A, Brisse E, <i> et al.</i>: Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. <i>Rheumatology (Oxford).</i> 2015; <b>54</b>(8): 1507–17. <a target=xrefwindow id=d81061e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/25767156">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2204 href="http://dx.doi.org/10.1093/rheumatology/keu524">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725388875">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d81061e2217 class=n-a></a>Sikora KA, Fall N, Thornton S, <i> et al.</i>: The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness. <i>Arthritis Rheum.</i> 2012; <b>64</b>(11): 3799–808. <a target=xrefwindow id=d81061e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/22740319">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2231 href="http://dx.doi.org/10.1002/art.34604">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2235 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3482423">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d81061e2244 class=n-a></a>Fall N, Barnes M, Thornton S, <i> et al.</i>: Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. <i>Arthritis Rheum.</i> 2007; <b>56</b>(11): 3793–804. <a target=xrefwindow id=d81061e2255 href="http://www.ncbi.nlm.nih.gov/pubmed/17968951">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2258 href="http://dx.doi.org/10.1002/art.22981">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d81061e2267 class=n-a></a>Ogilvie EM, Khan A, Hubank M, <i> et al.</i>: Specific gene expression profiles in systemic juvenile idiopathic arthritis. <i>Arthritis Rheum.</i> 2007; <b>56</b>(6): 1954–65. <a target=xrefwindow id=d81061e2278 href="http://www.ncbi.nlm.nih.gov/pubmed/17530721">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2281 href="http://dx.doi.org/10.1002/art.22644">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d81061e2291 class=n-a></a>Shimizu M, Nakagishi Y, Kasai K, <i> et al.</i>: Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. <i>Cytokine.</i> 2012; <b>58</b>(2): 287–94. <a target=xrefwindow id=d81061e2302 href="http://www.ncbi.nlm.nih.gov/pubmed/22398373">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2305 href="http://dx.doi.org/10.1016/j.cyto.2012.02.006">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d81061e2314 class=n-a></a>Shimizu M, Yokoyama T, Yamada K, <i> et al.</i>: Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. <i>Rheumatology (Oxford).</i> 2010; <b>49</b>(9): 1645–53. <a target=xrefwindow id=d81061e2325 href="http://www.ncbi.nlm.nih.gov/pubmed/20472718">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2328 href="http://dx.doi.org/10.1093/rheumatology/keq133">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d81061e2337 class=n-a></a>Jelusić M, Lukić IK, Tambić-Bukovac L, <i> et al.</i>: Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis. <i>Clin Rheumatol.</i> 2007; <b>26</b>(8): 1332–4. <a target=xrefwindow id=d81061e2348 href="http://www.ncbi.nlm.nih.gov/pubmed/17597334">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2351 href="http://dx.doi.org/10.1007/s10067-006-0474-0">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d81061e2360 class=n-a></a>Maeno N, Takei S, Nomura Y, <i> et al.</i>: Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima <i>et al.</i> <i>Arthritis Rheum.</i> 2002; <b>46</b>(9): 2539–41; author reply 2541–2. <a target=xrefwindow id=d81061e2374 href="http://www.ncbi.nlm.nih.gov/pubmed/12355506">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2378 href="http://dx.doi.org/10.1002/art.10389">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d81061e2387 class=n-a></a>Lotito AP, Campa A, Silva CA, <i> et al.</i>: Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. <i>J Rheumatol.</i> 2007; <b>34</b>(4): 823–30. <a target=xrefwindow id=d81061e2398 href="http://www.ncbi.nlm.nih.gov/pubmed/17343316">PubMed Abstract </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d81061e2407 class=n-a></a>Dinarello CA: Interleukin-18 and the pathogenesis of inflammatory diseases. <i>Semin Nephrol.</i> 2007; <b>27</b>(1): 98–114. <a target=xrefwindow id=d81061e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/17336692">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2418 href="http://dx.doi.org/10.1016/j.semnephrol.2006.09.013">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d81061e2428 class=n-a></a>Chiossone L, Audonnet S, Chetaille B, <i> et al.</i>: Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein. <i>Front Immunol.</i> 2012; <b>3</b>: 239. <a target=xrefwindow id=d81061e2439 href="http://www.ncbi.nlm.nih.gov/pubmed/22891066">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2442 href="http://dx.doi.org/10.3389/fimmu.2012.00239">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3413989">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d81061e2455 class=n-a></a>Canna SW, Girard C, Malle L, <i> et al.</i>: Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. <i>J Allergy Clin Immunol.</i> 2017; <b>139</b>(5): 1698–701. <a target=xrefwindow id=d81061e2466 href="http://www.ncbi.nlm.nih.gov/pubmed/27876626">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2469 href="http://dx.doi.org/10.1016/j.jaci.2016.10.022">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d81061e2478 class=n-a></a>Omoyinmi E, Hamaoui R, Pesenacker A, <i> et al.</i>: Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. <i>Rheumatology (Oxford).</i> 2012; <b>51</b>(10): 1881–6. <a target=xrefwindow id=d81061e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/22772320">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2492 href="http://dx.doi.org/10.1093/rheumatology/kes162">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3448884">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726192490"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2505 class=n-a></a>Beringer A, Noack M, Miossec P: IL-17 in Chronic Inflammation: From Discovery to Targeting. <i>Trends Mol Med.</i> 2016; <b>22</b>(3): 230–41. <a target=xrefwindow id=d81061e2513 href="http://www.ncbi.nlm.nih.gov/pubmed/26837266">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2516 href="http://dx.doi.org/10.1016/j.molmed.2016.01.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726192490">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717953621"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2529 class=n-a></a>van Vollenhoven RF, Fleischmann R, Cohen S, <i> et al.</i>: Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. <i>N Engl J Med.</i> 2012; <b>367</b>(6): 508–19. <a target=xrefwindow id=d81061e2540 href="http://www.ncbi.nlm.nih.gov/pubmed/22873531">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2543 href="http://dx.doi.org/10.1056/NEJMoa1112072">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717953621">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725755371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2556 class=n-a></a>Winthrop KL, Park SH, Gul A, <i> et al.</i>: Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(6): 1133–8. <a target=xrefwindow id=d81061e2567 href="http://www.ncbi.nlm.nih.gov/pubmed/26318385">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2570 href="http://dx.doi.org/10.1136/annrheumdis-2015-207319">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2574 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4893093">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725755371">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727365803"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2588 class=n-a></a>Winthrop KL: The emerging safety profile of JAK inhibitors in rheumatic disease. <i>Nat Rev Rheumatol.</i> 2017; <b>13</b>(4): 234–43. <a target=xrefwindow id=d81061e2596 href="http://www.ncbi.nlm.nih.gov/pubmed/28250461">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2599 href="http://dx.doi.org/10.1038/nrrheum.2017.23">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727365803">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d81061e2612 class=n-a></a>Schulert GS, Grom AA: Macrophage activation syndrome and cytokine-directed therapies. <i>Best Pract Res Clin Rheumatol.</i> 2014; <b>28</b>(2): 277–92. <a target=xrefwindow id=d81061e2620 href="http://www.ncbi.nlm.nih.gov/pubmed/24974063">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2623 href="http://dx.doi.org/10.1016/j.berh.2014.03.002">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4074772">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d81061e2635 class=n-a></a>Lin CI, Yu HH, Lee JH, <i> et al.</i>: Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. <i>Clin Rheumatol.</i> 2012; <b>31</b>(8): 1223–30. <a target=xrefwindow id=d81061e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/22615046">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2649 href="http://dx.doi.org/10.1007/s10067-012-1998-0">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726378879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2658 class=n-a></a>Maschalidi S, Sepulveda FE, Garrigue A, <i> et al.</i>: Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. <i>Blood.</i> 2016; <b>128</b>(1): 60–71. <a target=xrefwindow id=d81061e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/27222478">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2672 href="http://dx.doi.org/10.1182/blood-2016-02-700013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726378879">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726109283"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d81061e2686 class=n-a></a>Das R, Guan P, Sprague L, <i> et al.</i>: Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. <i>Blood.</i> 2016; <b>127</b>(13): 1666–75. <a target=xrefwindow id=d81061e2697 href="http://www.ncbi.nlm.nih.gov/pubmed/26825707">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2700 href="http://dx.doi.org/10.1182/blood-2015-12-684399">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2704 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4817310">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726109283">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d81061e2717 class=n-a></a>DeWitt EM, Kimura Y, Beukelman T, <i> et al.</i>: Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. <i>Arthritis Care Res (Hoboken).</i> 2012; <b>64</b>(7): 1001–10. <a target=xrefwindow id=d81061e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/22290637">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2731 href="http://dx.doi.org/10.1002/acr.21625">Publisher Full Text </a> | <a target=xrefwindow id=d81061e2735 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3368104">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d81061e2745 class=n-a></a>Kimura Y, DeWitt EM, Beukelman T, <i> et al.</i>: Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt <i>et al.</i> <i>Arthritis Care Res (Hoboken).</i> 2014; <b>66</b>(9): 1430–1. <a target=xrefwindow id=d81061e2759 href="http://www.ncbi.nlm.nih.gov/pubmed/24719268">PubMed Abstract </a> | <a target=xrefwindow id=d81061e2763 href="http://dx.doi.org/10.1002/acr.22343">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-971.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-971.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA<br/> <sup>2</sup> Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-971/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 22 Jun 2017, 6:971 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11327.1">https://doi.org/10.12688/f1000research.11327.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Canny S and Mellins E. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12227 data-id=11327 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11327.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-971/v1/pdf?article_uuid=8c303582-24cd-4f24-bc78-4a66d19083c0" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11327.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Canny S and Mellins E. New frontiers in the treatment of systemic juvenile idiopathic arthritis [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):971 (<a href="https://doi.org/10.12688/f1000research.11327.1" target=_blank>https://doi.org/10.12688/f1000research.11327.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11327 id=mobile-track-article-signin-11327 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11327?target=/articles/6-971.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12227 /> <input name=articleId type=hidden value=11327 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Randy Q Cron</strong>, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Children’s Hospital of Alabama, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Alexei Grom</strong>, Cincinnati Children’s Hospital Medical Center, Ohio, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-971.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-971.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23637-23719></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23636-23720></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-971/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>22 Jun 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Randy Q Cron</strong>, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Children’s Hospital of Alabama, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Alexei Grom</strong>, Cincinnati Children’s Hospital Medical Center, Ohio, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-971.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-971/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "New frontiers in the treatment of systemic...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-971/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-971/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-971/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Canny S and Mellins E');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-971/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-971",
            templates : {
                twitter : "New frontiers in the treatment of systemic juvenile idiopathic.... Canny S and Mellins E, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-971/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: New frontiers in the treatment of systemic juvenile idiopathic arthritis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: New frontiers in the treatment of systemic juvenile idiopathic arthritis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11327/12227")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12227");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "23719": 0,
                           "23720": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "c6231d0d-24ea-4a2f-bc54-0ffa5ed6c159";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-971.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-971.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-971.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-971.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-971.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>